Delivery Order SPE2DB22D1002-SPE2DB25FLGH6
- Not listed
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a competitively awarded delivery order from the Defense Logistics Agency valued at $1,687.48 for ProQuad vials. This contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999 through December 2026. The award was issued on August 19, 2025, with an ultimate completion date of...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $8,271.65 by the Defense Logistics Agency on July 22, 2025, for the supply of ProQuad vials. This competitively awarded, firm fixed-price contract carries an ultimate completion date of August 12, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $3,341.80 by the Defense Logistics Agency (DLA) for ProQuad vials, a vaccine product. The contract is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and carries no set-aside designation, indicating it was competitively awarded. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,687.48 by the Defense Logistics Agency on September 11, 2025, for the supply of ProQuad vials. This non-competitive, firm fixed-price delivery order is expected to be completed by October 2, 2025, with performance taking place at the vendor's Conshohocken facility. The award represents a child contract issued under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,670.90 by the Defense Logistics Agency for ProQuad vials, with an ultimate completion date of September 23, 2025. The contract employs firm fixed-price pricing and was awarded on a competitive basis without set-aside restrictions. Performance will take place at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $16,543.30 for ProQuad vials under a Defense Logistics Agency contract. The award, issued on September 2, 2025, with completion targeted for September 23, 2025, employs firm fixed-price terms with no set-aside designation. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and varicella, making this delivery order a component of the federal...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 29, 2025, for ProQuad vials with a ceiling value of $50,127. This is a firm fixed price, non-set-aside contract with an ultimate completion date of September 22, 2025. The delivery order is being performed at the company's corporate office location in Conshohocken, Pennsylvania. This award falls under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $16,874.40 by the Defense Logistics Agency on August 11, 2025, for the supply of ProQuad vials with an ultimate completion date of September 2, 2025. This is a firm fixed-price contract with no set-aside designation, executed through open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the company's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a $16,543.30 delivery order to AmerisourceBergen Drug Corp on June 30, 2025, for ProQuad vials with a completion date of July 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement. The delivery order will be performed at the...
- SPE2DB22D1002Indefinite Delivery Contract
- SPE2DB22D1002-SPE2DB25FLGH6Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order from the Defense Logistics Agency valued at $1,654.33 for ProQuad vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of September 5, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, making this delivery order part of the company's comprehensive pharmaceutical supply support to military healthcare systems. This delivery order reflects AmerisourceBergen's ongoing role as a critical vendor within the Defense Logistics Agency's Medical Supply Chain, supplying a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. The award demonstrates the company's capability to fulfill federal procurement requirements through competitive acquisition and its versatility in managing transactions across various value ranges. As the DLA Troop Support prepares to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, AmerisourceBergen continues to serve as a key provider for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 8/14/25 |